SunTrust Robinson Humphrey Begins Coverage on Editas Medicine, Inc. (EDIT) Giving It An Initial Rating Of “Hold” – Highlight Press
|
SunTrust Robinson Humphrey Begins Coverage on Editas Medicine, Inc. (EDIT) Giving It An Initial Rating Of “Hold”
Highlight Press CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular … |
